-GiEatfNRL0 https://histock.tw/talk/live.aspx?name=gtalk&id=1410 20260722 阿布波

台股 » 個股 » 順藥 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

順藥

(6535)
  • 股價
    89.4
  • 漲跌
    ▲2.5
  • 漲幅
    +2.88%
  • 成交量
    155
  • 產業
    上櫃 生技醫療類股
  • 83人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
順藥 (6535)籌碼相關-第一金-自由 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

第一金-自由 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2026/07/21186.9000.0086.9012410.41%
2026/07/17190.5000.0090.2012410.41%
2026/07/13198.6000.0098.3012410.41%
2026/07/062112.0000.00106.5022440.82%
2026/06/26298.5000.0097.0022320.86%
2026/06/183102.0000.00103.0032241.33%
2026/06/101108.5000.00108.0012220.45%
2026/06/0910112.2000.00110.50102214.52%
2026/06/045116.0000.00115.5052152.32%
2026/06/025123.0000.00121.5052072.41%
2026/05/274124.0000.00124.0042021.98%
2026/05/261124.0000.00125.0012010.50%
2026/05/255125.0000.00127.0052012.48%
2026/05/222126.0000.00127.5022001.00%
2026/05/183126.5000.00126.5032091.43%
2026/05/132129.0000.00128.5022220.90%
2026/04/241125.0000.00125.0012110.47%
2026/04/2300.002128.00128.50-2213-0.94%
2026/04/224129.5000.00130.0042091.91%
2026/04/142133.0000.00137.0022070.96%
2026/04/132135.0000.00134.5022050.97%
2026/04/101139.0000.00139.0012060.49%
2026/04/091138.0000.00138.0012080.48%
2026/03/021166.5000.00169.0012340.43%
2026/02/252177.0000.00177.0022370.84%
2026/02/112177.2500.00179.0022420.82%
2026/02/0500.001.8183.50179.00-1.8230-0.78%
2026/01/2300.005179.50179.50-5273-1.83%
2026/01/2000.008181.00181.00-8349-2.29%
2025/12/010.1217.0000.00202.000.17150.01%
2025/11/281204.5000.00217.5017300.14%
2025/11/115184.8000.00187.0058190.61%
2025/11/0400.000.3203.00200.00-0.3854-0.04%
2025/11/030.1212.0000.00211.500.18560.01%
2025/10/301210.9900.00205.0018500.12%
2025/10/291225.5000.00227.5018320.12%
2025/10/284244.7600.00245.0048150.49%
2025/10/272.2259.5100.00271.002.27930.27%
2025/10/232.1279.0000.00279.002.17630.28%
2025/10/221.1305.7600.00310.001.17440.14%
2025/10/210.2319.252312.50319.00-1.8726-0.25%
2025/10/2000.002299.00296.50-2704-0.28%
2025/10/162291.0000.00288.5026920.29%
2025/10/1500.001296.00297.00-1685-0.15%
2025/10/131263.5000.00284.5016780.15%
2025/10/092269.7500.00271.0026680.30%
2025/10/074284.250280.00279.0046560.61%
2025/10/031294.001298.50294.0006390.00%
2025/10/022295.2500.00291.5026370.31%
2025/10/011292.071306.50296.0006340.00%
2025/09/264283.2500.00286.0046230.64%
2025/09/2511290.5916283.06293.00-5615-0.81%
2025/09/232308.5000.00303.0025900.34%
2025/09/2200.000.1303.00300.50-0.1583-0.02%
2025/09/1900.003313.00312.00-3574-0.52%
2025/09/182326.2500.00318.5025620.36%
2025/09/172318.0000.00318.0025500.36%
2025/09/161308.0000.00319.0015410.18%
2025/09/1000.003283.50287.50-3489-0.61%
2025/09/093.1260.6400.00261.503.14680.65%
2025/09/085258.1000.00262.0054551.10%
2025/09/052236.0000.00242.0024370.46%
2025/09/041238.0000.00238.5014300.23%
2025/09/036233.5000.00240.0064131.45%
2025/08/220.6198.0800.00197.000.63240.18%
2025/08/150171.0000.00170.5002950.01%
順藥中風新藥下半年啟動中國二/三期無縫試驗 持續尋求授權與合作機會Anue鉅亨-2026/05/15
順藥 相關文章
順藥 相關影音